Interv Akut Kardiol. 2020;19(1):39-46 | DOI: 10.36290/kar.2020.017

Functional myocardial revascularization

Tomáš Kovárník1, Štěpán Jeřábek1, Petr Kala2
1 II. interní klinika - kardiologie a angiologie, Všeobecná fakultní nemocnice a 1. LF UK, Praha
2 Fakultní nemocnice Brno a LF MU, Brno

The concept of functional revascularization has been broadly accepted. Although the best clinical evidence has been provided in patients with chronic coronary syndromes, recent data strongly advocate its use also in patients with acute coronary syndromes. Invasive pressure-derived indexes: hyperemic FFRmyo (myocardial fractional flow reserve) and resting iFR (instantaneous free ratio) or others require an interventional procedure by wiring the diseased vessel. Values of FFRmyo ≤ 0.80 and of iFR ≤ 0.89 are suggestive of functionally significant coronary disease mostly indicated for revascularization. Moreover there are several non-invasive functional tests that can be used in clinical practice: perfusion scintigraphy, cardiovascular magnetic resonance and positron emission tomography, and the recently introducer FFRCT or quantitative flow ratio (QFR). In routine practice, the concept of functional revascularization avoids unnecessary coronary interventions and, in the case of functionally non-significant disease/stenoses, the patients may be treated conservatively with a very good prognosis. Currently, the "functionally complete revascularization", instead of ananatomical one, should become our new target of treatment.

Keywords: functional revascularization, myocardial ischemia, FFR, revascularization, pressure gradient.

Published: June 1, 2020  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Kovárník T, Jeřábek Š, Kala P. Functional myocardial revascularization. Interv Akut Kardiol. 2020;19(1):39-46. doi: 10.36290/kar.2020.017.
Download citation

References

  1. Pijls NH, Van Gelder B, Van der Voort P, et al. Fractional flow reserve. A useful index to evaluate the influence of an epicardial coronary stenosis on myocardial blood flow. Circulation 1995; 92: 3183-3193. Go to original source... Go to PubMed...
  2. Sen S, Esaned J, Malik I, et al. Development and validation of a new adenosin-independent index of stenosis severity from coronary wave-intensity analysis. JACC 2012; 59: 1392-1402. Go to original source... Go to PubMed...
  3. Lee JM, Shin ES, Nam ChW, et al. Discrepancy between fractional flow reserve and instantaneous wave-free ratio: Clinical and angiographic characteristics. International journal of cardiology 2017; 245: 63-68. Go to original source... Go to PubMed...
  4. Neumann FJ, Sousa-Uva M, Ahlsson A, et al. 2018 ESC/EACTS Guidelines on myocardial revascularization European Heart Journal 2018; 00: 1-96. Go to original source... Go to PubMed...
  5. Svanerud J, Ahn JM, Jeremias A, et al. Validation of a novel non-hyperaemic index of coronary artery stenosis severity: the Resting Full-cycle Ratio (VALIDATE RFR) study. EuroIntervention 2018; 14: 806-814. Go to original source... Go to PubMed...
  6. Johnson NP, Li W, Chen X, et al. Diastolic pressure ratio: new approach and validation vs. the instantaneous wave-free ratio. European Heart Journal 2019; 40: 2585-2594. Go to original source... Go to PubMed...
  7. Ligthart J, Masdjedi K, Witberg K, et al. Validation of Resting Diastolic Pressure Ratio Calculated by a Novel Algorithm and Its Correlation With Distal Coronary Artery Pressure to Aortic Pressure, Instantaneous Wave-Free Ratio, and Fractional Flow Reserve. Circ Cardiovasc Interv. 2018; 11: e006911. Go to original source... Go to PubMed...
  8. Uren NG, Melin JA, De Bruyne B, et al. Relation between myocar - dial blood flow and the severity of coronary-artery stenosis. N Engl J Med. 1994; 330: 1782-1788. Go to original source... Go to PubMed...
  9. Fearon WF, Balsam LB, Farouque HM, et al. Novel index for invasively assessing the coronary microcirculation. Circulation 2003; 107: 3129-3132. Go to original source... Go to PubMed...
  10. Solberg OG, Ragnarsson A, Kvarsnes A, et al. Reference interval for the index of coronary microvascular resistence. Eurointervention 2014; 9: 1069-1075. Go to original source... Go to PubMed...
  11. Van de Hoef T, van Lavieren M, Damman P, et al. Physiological Basis and Long-Term Clinical Outcome of Discordance Between Fractional Flow Reserve and Coronary Flow Velocity Reserve in Coronary Stenoses of Intermediate Severity. Circ. CardioVasc. Interv. 2014; 7: 301-311. Go to original source... Go to PubMed...
  12. Petraco R, van de Hoef T, Nijjer S, et al. Baseline Instantaneous Wave-Free Ratio as a Pressure-Only Estimation of Underlying Coronary Flow Reserve. Circ. CardioVasc. Interv. 2014; 7: 492-502. Go to original source... Go to PubMed...
  13. Davies JE, Sen S, Dehbi HM, et al. Use of the instantaneous wave-free ratio or fractional flow reserve in PCI. N Engl J Med 2017; 376: 1824-1834. Go to original source... Go to PubMed...
  14. Gotberg M, Christiansen EH, Gudmundsdottir IJ, et al. iFR - SWEDEHEART Investigators. Instantaneous wave-free ratio versus fractional flow reserve to guide PCI. N Engl J Med. 2017; 376: 1813-1823. Go to original source... Go to PubMed...
  15. Jerabek S, Zemanek D, Pudil J, et al. Endothelial dysfunction assessed by digital tonometry and discrepancy between fraction flow reserve and instantaneous wave free ratio. Acta Cardiologica 2019; 4: 1-6. Go to original source... Go to PubMed...
  16. Xaplanteris P, Ntalianis A, De Bruyne B, et al. Coronary lesion progression as assessed by fractional flow reserve (FFR) and angiography. Eurointervention 2018; 14: 907-914. Go to original source... Go to PubMed...
  17. Ford T, Berry C, De Bruyne B, et al. Physiological predictors of acute coronary syndromes emerging insights from the plaque to the vulnerable patient. JACC CVI 2017; 10: 2539-2467. Go to original source...
  18. Zimmermann F, Ferrara A, Johnson N, et al. Deferral vs. performance of percutaneous coronary intervention of functionally non-significant coronary stenosis: 15-year follow-up of the DEFER trial. Europena Heart J. 2015; 36: 3182-3188. Go to original source... Go to PubMed...
  19. Tu S, Westra J, Yang J, et al. Diagnostic accuracy of fast computational approaches to derive fractional flow reserve from diagnostic coronary angiography: the International Multicenter FAVOR Pilot Study. JACC Cardiovasc Interv 2016; 9: 2024-2035. Go to original source... Go to PubMed...
  20. Westra J, Tu S, Winther S, et al. Evaluation of coronary artery stenosis by quantitative flow ratio during invasive coronary angiography: the WIFI II Study (Wire-Free Functional Imaging II). Circ Cardiovasc Imaging. 2018; 11: e007107. Go to original source... Go to PubMed...
  21. Sejr-Hansen M, Westra J, Thim T, et al. Quantitative flow ratio for immediate assessment of nonculprit lesions in patients with ST-segment elevation myocardial infarction - an iSTEMI substudy. Catheter Cardiovasc Interv. 2019; 94: 686-692 Go to original source... Go to PubMed...
  22. Sejr‑Hansen M, Westra J, Winther S, et al. Comparison of quantitative flow ratio and fractional flow reserve with myocardial perfusion scintigraphy and cardiovascular magnetic resonance as reference standard. A Dan-NICAD substudy. The International Journal of Cardiovascular Imaging 2019; Nov 19. doi: 10.1007/s10554-019-01737-z. Go to original source... Go to PubMed...
  23. Patel MR, Nørgaard BL, Fairbairn TA, et al. 1-Year Impact on Medical Practice and Clinical Outcomes of FFRCT: The ADVANCE Registry. JACC Cardiovasc Imaging. 2020; 13: 97-105. Go to original source... Go to PubMed...
  24. Fearon W, De Bruyne B, Pijls H. Fractional Flow Reserve in Acute Coronary Syndromem. JACC 2016; 68: 1192-1194. Go to original source... Go to PubMed...
  25. Kobayashi Y, Nam CW, Tonino PA, et al. FAME Study Investigators. The prognostic value of re-sidual coronary stenoses after functionally complete revascularization. J Am Coll Cardiol 2016; 67: 1701-1711. Go to original source... Go to PubMed...
  26. Pijls NH, Klauss V, Siebert U, et al. Coronary pressure measurement after stenting predicts adverse events at follow-up: a multicenter registry. Circulation 2002; 105: 2950-2954. Go to original source... Go to PubMed...
  27. Nam CW, Hur SH, Cho YK, et al. Relation of fractional flow reserve after drug-eluting stent implantation to one-year outcomes. Am J Cardiol 2011; 107: 1763-1767. Go to original source... Go to PubMed...
  28. Doh JH, Nam CW, Koo BK, et al. Clinical relevance of poststent fractional flow reserve after drug-eluting stent implantation. J Invasive Cardiol 2015; 27: 346-351. Go to PubMed...
  29. Beller GA, Zaret B. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation 2001; 10: 1465-1478. Go to original source...
  30. Sajadieh A, Nielsen OW, Rasmussen V, et al. Prevalence and prognostic significance of daily-life silent myocardial ischaemia in middle-aged elderly subjects with no apparent heart disease. Eur Heart J 2005; 26: 1402-1409. Go to original source... Go to PubMed...
  31. Farzaneh-Far A, Phillips HR, Shaw LK, et al. Ischemia change in stable coronary artery disease is an independent predictor of death and myocardial infarction. JACC Cardiovasc Imaging. 2012; 5: 715-724. Go to original source... Go to PubMed...
  32. Shaw L, Cerqueira M, Brooks M, et al. Impact of left ventricular function and the extent of ischemia and scar by stress myocardial perfusion imaging on prognosis and therapeutic risk reduction in diabetic patients with coronary artery disease: Results from the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial. J Nucl Cardiol. 2012; 19: 658-669. Go to original source... Go to PubMed...
  33. Panza JA, Holly TA, Asch FM, et al. Inducible Myocardial Ischemia and Outcomes in Patients with Coronary Artery Disease and Left Ventricular Dysfunction. J Am Coll Cardiol. 2013; 61: 1860-1870. Go to original source... Go to PubMed...
  34. Shaw LJ, Weintraub WS, Maron DJ, et al. Baseline stress myocardial perfusion imaging results and outcomes in patients with stable ischemic heart disease randomized to optimal medical therapy with or without percutaneous coronary intervention. Am Heart J 2012; 164: 243-250. Go to original source... Go to PubMed...
  35. Mancini J, Hartigan P, Shaw L, et al. Predicting Outcome in the COURAGE Trial (Clinical Outcomes Utilizing Revascularization and Aggressive Drug Evaluation) Coronary Anatomy Versus Ischemia. J Am Coll Cardiol Intv 2014; 7: 195-201. Go to original source... Go to PubMed...
  36. De Bruyne B, Pijls NH, Kalesan B, et al. Fractional flow reserve-guided PCI versus medical therapy in stable coronary disease. N Engl J Med 2012; 367: 991-1001. Go to original source... Go to PubMed...
  37. Xaplanteris P, Fournier S, Pijls N, et al. Five-Year Outcomes with PCI Guided by Fractional Flow Reserve. NEJM 2018; 379: 250-259. Go to original source... Go to PubMed...
  38. www.ischemiatrial.org.
  39. Mehta S, Wood D, Storey R, et al. Complete revascularization with multivessel PCI for myoacrdial infarction. N Engl J Med. 2019; 381: 1411-1421. Go to original source... Go to PubMed...
  40. Smits P, Abdel-Wahab M, Neumann F, et al. Fractional Flow Reserve-Guided Multivessel Angioplasty in Myocardial Infarction. N Engl J Med. 2017; 376: 1234-1244. Go to original source... Go to PubMed...
  41. Lønborg J, Engstrøm T, Kelbæk H, et al. Fractional Flow Reserve-Guided Complete Revascularization Improves the Prognosis in Patients With ST-Segment-Elevation Myocardial Infarction and Severe Nonculprit Disease. A DANAMI 3-PRIMULTI Substudy (Primary PCI in Patients With ST-Elevation Myocardial Infarction and Multivessel Disease: Treatment of Culprit Lesion Only or Complete Revascularization). Circulation CVI 2017; 10: e004860. Go to original source... Go to PubMed...




Interventional Cardiology

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.